Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

October 28, 2015

Primary Completion Date

June 2, 2017

Study Completion Date

June 2, 2017

Conditions
Peripheral Arterial DiseaseIntermittent Claudication
Interventions
DRUG

Danshen Gegen Capsule

"Danshen can dilate blood vessels, reduce the number of angina attacks and significantly improve endothelial function in patients with Coronary Angina Pectoris.~Gegen is also effective in dilating cardiovascular and cerebrovascular of the brain, and improving blood circulation. The main active ingredient of Gegen isoflavones is effective in dilating the coronary arteries, improving metabolism in normal and ischemic myocardium and reducing blood pressure, heart rate and myocardial oxygen consumption."

DRUG

Placebo

Trial Locations (1)

Unknown

Prince of Wales Hospital, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT02380794 - Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule | Biotech Hunter | Biotech Hunter